Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Andrew_Allen
|
| gptkbp:clinicalTrialPhase |
GRANITE
SLATE |
| gptkbp:collaboratesWith |
gptkb:bluebird_bio
gptkb:Bristol_Myers_Squibb |
| gptkbp:developedBy |
immunotherapies
neoantigen-based cancer vaccines |
| gptkbp:focusesOn |
immunotherapy
personalized cancer vaccines infectious disease vaccines |
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
gptkb:Andrew_Allen
Timothy A. Langer |
| gptkbp:headquartersLocation |
gptkb:Emeryville,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gritstone Oncology
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:numberOfEmployees |
100-200
|
| gptkbp:stockSymbol |
gptkb:GRTS
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.gritstonebio.com/
|
| gptkbp:bfsParent |
gptkb:The_Column_Group
|
| gptkbp:bfsLayer |
7
|